Sunteți pe pagina 1din 2

Federal Register / Vol. 70, No.

220 / Wednesday, November 16, 2005 / Notices 69579

II. Comments Bethesda, MD 20892–9300. (301) 451–2020. DEPARTMENT OF HEALTH AND


aes@nei.nih.gov. HUMAN SERVICES
Interested persons may submit to the
Division of Dockets Management (see (Catalogue of Federal Domestic Assistance
ADDRESSES) written or electronic Program Nos. 93.867, Vision Research, National Institutes of Health
comments regarding this document. National Institutes of Health, HHS)
National Institute of Allergy and
Submit a single copy of electronic Dated: November 4, 2005. Infectious Diseases; Notice of Closed
comments or two paper copies of any Anna Snouffer, Meeting
mailed comments, except that Acting Director, Office of Federal Advisory
individuals may submit one paper copy. Committee Policy. Pursuant to section 10(d) of the
Comments are to be identified with the [FR Doc. 05–22691 Filed 11–15–05; 8:45 am] Federal Advisory Committee Act, as
docket number found in brackets in the amended (U.S.C. Appendix 2), notice is
BILLING CODE 4140–01–M
heading of this document. The draft hereby given of the following meetings.
guidance and received comments may The meetings will be closed to the
be seen in the Division of Dockets public in accordance with the
DEPARTMENT OF HEALTH AND
Management between 9 a.m. and 4 p.m., provisions set forth in sections
HUMAN SERVICES
Monday through Friday. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
National Institutes of Health as amended. The grant applications and
III. Electronic Access the discussions could disclose
Persons with access to the Internet National Heart, Lung, and Blood confidential trade secrets or commerical
may obtain the document at either Institute; Notice of Closed Meeting property such as patentable material,
http://www.fda.gov/cder/guidance/ and personal information concerning
index.htm or http://www.fda.gov/ Pursuant to section 10(d) of the individuals associated with the grant
ohrms/dockets/default.htm. Federal Advisory Committee Act, as applications, the disclosure of which
Dated: November 8, 2005. amended (5 U.S.C. Appendix 2), notice would constitute a clearly unwarranted
Jeffrey Shuren, is hereby given of the following invasion of personal privacy.
Assistant Commissioner for Policy. meeting. Name of Committee: National Institute of
[FR Doc. 05–22754 Filed 11–15–05; 8:45 am] The meeting will be closed to the Allergy and Infectious Diseases Special
BILLING CODE 4160–01–S public in accordance with the Emphasis Panel, RFA–05–015 ‘‘Clinical
Outcomes of Live Organ Donors’’.
provisions set forth in sections Date: December 1–2, 2005.
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Time: 9 a.m. to 5 p.m.
DEPARTMENT OF HEALTH AND as amended. The grant applications and Agenda: To review and evaluate grant
HUMAN SERVICES the discussions could disclose applications.
confidential trade secrets or commercial Place: Double Tree Rockville, 1750
National Institutes of Health property such as patentable material, Rockville Pike, Rockville, MD 20852.
and personal information concerning Contact Person: Kenneth E. Santora, PhD,
National Eye Institute; Notice of Closed Scientific Review Administrator, Scientific
Meeting individuals associated with the grant
applications, the disclosure of which Review Program, Division of Extramural
Pursuant to section 10(d) of the Activities, NIAID/NIH/DHHS, Room 3265,
would constitute a clearly unwarranted 6700B Rockledge Drive, MSC 7616, Bethesda,
Federal Advisory Committee Act, as invasion of personal privacy. MD 20892, (301) 451–2605, ks216i@nih.gov.
amended (5 U.S.C. Appendix 2), notice Name of Committee: National Heart, Lung, (Catalogue of Federal Domestic Assistance
is hereby given of the following and Blood Institute Special Emphasis Panel, Program Nos. 93.855, Allergy, Immunology,
meeting. Clinical Trial Review. and Transplantation Research; 93.856,
The meeting will be closed to the Date: December 5, 2005. Microbiology and Infectious Diseases
public in accordance with the Time: 12 p.m. to 3 p.m. Research, National Institutes of Health, HHS)
provisions set forth in sections Agenda: To review and evaluate grant Dated: November 7, 2005.
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., applications.
as amended. The grant applications and Anna Snouffer,
Place: National Institutes of Health, 6701
the discussions could disclose Deputy Director, Office of Federal Advisory
Rockledge Drive, Bethesda, MD 20892,
confidential trade secrets or commercial Committee Policy.
(Telephone Conference Call).
property such as patentable material, [FR Doc. 05–22682 Filed 11–15–05; 8:45 am]
Contact Person: William J. Johnson, PhD,
and personal information concerning Review Branch, Division of Extramural BILLING CODE 4140–01–M
individuals associated with the grant Affairs, NIH/NHLBI, 6701 Rockledge Drive,
applications, the disclosure of which Bethesda, MD 20892–7924, 301–435–0317,
would constitute a clearly unwarranted johnsonw@nhibi.nih.gov. DEPARTMENT OF HEALTH AND
invasion of personal privacy. HUMAN SERVICES
(Catalogue of Federal Domestic Assistance
Name of Committee: National Eye Institute Program Nos. 93.233, National Center for National Institutes of Health
Special Emphasis Panel. NEI Clinical Sleep Disorders Research; 93.837, Heart and
applications. Vascular Diseases Research; 93.838, Lung National Institute of Biomedical
Date: November 21, 2005. Diseases Research; 93.839, Blood Diseases Imaging and Bioengineering; Notice of
Time: 8 a.m. to 5 p.m. and Resources Research, National Institutes Closed Meetings
Agenda: To review and evaluate grant of Health, HHS)
applications. Pursuant to section 10(d) of the
Place: Embassy Suites at the Chevy Chase Dated: November 7, 2005.
Federal Advisory Committee Act, as
Pavilion, 4300 Military Road, NW., Anna Snouffer,
Washington, DC 20015.
amended (5 U.S.C. Appendix 2), notice
Acting Director, Office of Federal Advisory is hereby given of the following
Contact Person: Anne E. Schaffner, PhD, Committee Policy.
Scientific Review Administrator, Division of meetings.
Extramural Research, National Eye Institute, [FR Doc. 05–22684 Filed 11–15–05; 8:45 am] The meetings will be closed to the
5635 Fishers Lane, Suite 1300, MSC 9300, BILLING CODE 4140–01–M public in accordance with the

VerDate Aug<31>2005 13:56 Nov 15, 2005 Jkt 208001 PO 00000 Frm 00072 Fmt 4703 Sfmt 4703 E:\FR\FM\16NON1.SGM 16NON1
69580 Federal Register / Vol. 70, No. 220 / Wednesday, November 16, 2005 / Notices

provisions set forth in sections provisions set forth in sections would constitute a clearly unwarranted
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., invasion of personal privacy.
as amended. The grant applications and as amended. The grant applications and Name of Committee: National Institute of
the discussions could disclose the discussions could disclose Diabetes and Digestive and Kidney Diseases
confidential trade secrets or commercial confidential trade secrets or commercial Special Emphasis Panel. Review of R03 Grant
property such as patentable material, property such as patentable material, Application.
and personal information concerning and personal information concerning Date: November 28, 2005.
individuals associated with the grant individuals associated with the grant Time: 2 p.m. to 3 p.m.
applications, the disclosure of which applications, the disclosure of which Agenda: To review and evaluate grant
would constitute a clearly unwarranted would constitute a clearly unwarranted applications.
Place: National Institutes of Health, Two
invasion of personal privacy. invasion of personal privacy. Democracy Plaza, 6707 Democracy
Name of Committee: National Institute of Name of Committee: National Institute on Boulevard, Bethesda, MD 20892. (Telephone
Biomedical Imaging and Bioengineering Drug Abuse Special Emphasis Panel, Review Conference Call).
Special Emphasis Panel, NIH–NIBIB P01–J3 of Time Sensitive Applications. Contact Person: Neal A. Musto, PhD,
Review Meeting. Date: November 14, 2005. Scientific Review Administrator, Review
Date: November 18, 2005. Time: 2 p.m. to 6 p.m. Branch, DEA, NIDDK, National Institutes of
Time: 8 a.m. to 1:30 p.m. Agenda: To review and evaluate grant Health, Room 751, 6707 Democracy
Agenda: To review and evaluate grant applications. Boulevard, Bethesda, MD 20892–5452. (301)
applications. Place: National Institutes of Health, 6101 594–7798. muston@extra.niddk.nih.gov.
Place: Bethesda Park Hotel, 840 Wisconsin Executive Boulevard, Rockville, MD 20852, This notice is being published less than 15
Avenue, Bethesda, MD 20814. (Telephone Conference Call). days prior to the meeting due to the timing
Contact Person: Prabha L. Atreya, PhD, Contact Person: Meenaxi Hiremath, PhD, limitations imposed by the review and
Scientific Review Administrator, Office of Health Scientist Administrator, Office of funding cycle.
Scientific Review, National Institute of Extramural Affairs, National Institute on
(Catalogue of Federal Domestic Assistance
Biomedical Imaging, and Bioengineering, Drug Abuse, National Institutes of Health,
Program Nos. 93.847, Diabetes,
Bethesda, MD 20892, (301) 496–8633, DHHS, 6101 Executive Blvd., Suite 220, MSC
Endocrinology and Metabolic Research;
atreyapr@mail.nih.gov. 8401, Bethesda, MD 20892, 301–402–7964,
93.848, Digestive Diseases and Nutrition
This notice is being published less than 15 mh392g@nih.gov.
Research; 93.849, Kidney Diseases, Urology
days prior to the meeting due to the timing This notice is being published less than 15
and Hematology Research, National Institutes
limitations imposed by the review and days prior to the meeting due to the timing
of Health, HHS)
funding cycle. limitations imposed by the review and
funding cycle. Dated: November 4, 2005.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering (Catalogue of Federal Domestic Assistance Anna Snouffer,
Special Emphasis Panel, NIBIB–R13 Program Nos. 93.306, Comparative Medicine; Acting Director, Office of Federal Advisory
Conference Review Meeting. 93.333, Clinical Research; 93.306, 93.333, Committee Policy.
Date: December 7, 2005. 93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National [FR Doc. 05–22687 Filed 11–15–05; 8:45 am]
Time: 10 a.m. to 12:30 p.m. BILLING CODE 4140–01–M
Agenda: To review and evaluate grant Institutes of Health, HHS)
applications. Dated: November 7, 2005.
Place: II Democracy Plaza, Dem. II, 6707 Anna Snouffer,
Democracy Blvd. 223, Bethesda, MD 20817, DEPARTMENT OF HEALTH AND
Acting Director, Office of Federal Advisory HUMAN SERVICES
(Telephone Conference Call).
Committee Policy.
Contact Person: Bonnie Dunn, PhD,
Scientific Review Administrator, Office of [FR Doc. 05–22686 Filed 11–15–05; 8:45 am] National Institutes of Health
Scientific Review, National Institute of BILLING CODE 4140–01–M
Biomedical Imaging and Bioengineering, National Institute of Neurological
6707 Democracy Blvd., Suite 920, Bethesda, Disorders and Stroke; Notice of Closed
MD 20892, (301) 496–8633, DEPARTMENT OF HEALTH AND Meetings
dunnbo@mail.nih.gov. HUMAN SERVICES Pursuant to section 10(d) of the
Dated: November 7, 2005. Federal Advisory Committee Act, as
Anna Snouffer,
National Institutes of Health
amended (5 U.S.C. Appendix 2), notice
Acting Director, Office of Federal Advisory National Institute of Diabetes and is hereby given of the following
Committee Policy. Digestive and Kidney Diseases; Notice meetings.
[FR Doc. 05–22683 Filed 11–15–05; 8:45 am] of Closed Meeting The meetings will be closed to the
BILLING CODE 4140–01–M public in accordance with the
Pursuant to section 10(d) of the provisions set forth in sections
Federal Advisory Committee Act, as 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
DEPARTMENT OF HEALTH AND amended (5 U.S.C. Appendix 2), notice as amended. The grant applications and
HUMAN SERVICES is hereby given of the following the discussions could disclose
meeting. confidential trade secrets or commercial
National Institutes of Health The meeting will be closed to the property such as patentable material,
public in accordance with the and personal information concerning
National Institute on Drug Abuse; provisions set forth in sections individuals associated with the grant
Notice of Closed Meeting 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., applications, the disclosure of which
Pursuant to section 10(d) of the as amended. The grant applications and would constitute a clearly unwarranted
Federal Advisory Committee Act, as the discussions could disclose invasion of personal privacy.
amended (5 U.S.C. Appendix 2), notice confidential trade secrets or commercial Name of Committee: National Institute of
is hereby given of the following property such as patentable material, Neurological Disorders and Stroke Special
meeting. and personal information concerning Emphasis Panel. Fellowship Review.
The meeting will be closed to the individuals associated with the grant Date: November 29, 2005.
public in accordance with the applications, the disclosure of which Time: 8 a.m. to 5 p.m.

VerDate Aug<31>2005 13:56 Nov 15, 2005 Jkt 208001 PO 00000 Frm 00073 Fmt 4703 Sfmt 4703 E:\FR\FM\16NON1.SGM 16NON1

S-ar putea să vă placă și